What weight loss should I expect?

Trial averages: semaglutide 2.4 mg about 14.9% at 68 weeks (STEP-1); tirzepatide 15 mg about 22.5% at 72 weeks (SURMOUNT-1). Individual results vary widely.

How long until I see results?

Most patients notice appetite changes within 1-2 weeks and measurable weight reduction by week 4-8. Maximal weight loss typically continues through 60-72 weeks of continuous therapy.

Will I keep the weight off if I stop?

Trial data (STEP-4) suggest most patients regain about two-thirds of lost weight within a year of stopping. GLP-1s are increasingly treated as long-term therapy.

What's the most cost-effective program?

Compounded telehealth options start at $149/month. We currently rank Embody highest for entry-tier pricing and Eden Health for flat-rate predictability.

Is GLP-1 Evolution biased?

We earn affiliate commissions from some providers we recommend. We disclose this openly and base rankings on consumer value, not commission size. Our editorial standards are public.

Which GLP-1 telehealth provider is most affordable in 2026?

Eden Health currently offers the lowest entry pricing among the vetted compounded GLP-1 telehealth providers we review, starting near $196/month for compounded semaglutide. SkinnyRx is the next tier at $199/month and adds Affirm financing for users who want to spread payments. Pricing changes frequently — verify the current rate on the provider's site before signing up.

Which GLP-1 telehealth has the highest customer satisfaction?

Eden Health and SHED consistently score highest on public review aggregators (Trustpilot, Reddit threads) for customer support responsiveness and refill reliability as of May 2026. Embody Health scores highest for users who want lifestyle coaching bundled with their prescription. Satisfaction is highly use-case dependent — the cheapest option is rarely the most satisfying.

Are compounded semaglutide and tirzepatide legal in 2026?

Yes, when prescribed by a licensed clinician and dispensed through a 503A or 503B compounding pharmacy registered with the FDA. The FDA's Drug Shortage list for semaglutide and tirzepatide officially resolved in early 2025, which narrowed the legal pathway. Compounding remains legal under personalization exemptions (e.g., dose adjustments, allergen exclusions) and through 503B outsourcing facilities. The FDA sent warning letters to ~30 telehealth companies in March 2026, but those targeted marketing language, not the legality of compounded products themselves. Read our deep-dive: /compounded-glp1-2026-legal.html

How long does it take to see results with GLP-1 medications?

Appetite suppression typically begins within 1-2 weeks of the first dose. Measurable weight loss usually starts in weeks 4-8 as the dose escalates. The STEP-1 trial (PMID 33567185) showed 14.9% mean weight loss over 68 weeks with semaglutide 2.4mg. The SURMOUNT-1 trial (PMID 35658024) showed 22.5% mean weight loss over 72 weeks with tirzepatide 15mg. Individual results vary based on adherence, dose, baseline weight, and lifestyle factors.

Which provider has the best refund policy?

Refund policies vary widely and change frequently. SHED and Embody Health have historically offered the most flexible cancellation terms (cancel anytime, no contract). SkinnyRx and GobyMeds operate on month-to-month subscriptions. Compounded medications, once shipped, are generally non-refundable across all providers due to FDA regulations on returned pharmaceuticals. Always read the current Terms of Service before paying.

Can I switch GLP-1 providers without losing weight loss progress?

Yes. Weight loss progress is driven by the active molecule (semaglutide, tirzepatide) and your dose, not the provider. When switching, ask the new provider's clinician to match your current dose and continue your escalation schedule. Bring your most recent prescription label or pharmacy fill record. The transition is typically seamless — most users do not regress when switching providers if dose continuity is maintained.

Which provider supports oral GLP-1 (Wegovy pill / oral tablet)?

SkinnyRx is the only provider in our current review set that offers a compounded oral tablet formulation in addition to injectable semaglutide. Brand-name oral semaglutide (Rybelsus) is available through standard pharmacies with a prescription from any telehealth provider, but it is dosed for type 2 diabetes — not weight loss specifically. The FDA-approved oral semaglutide for weight loss (high-dose oral) is expected in late 2026.

How do GLP-1 telehealth providers compare on side effect support?

Embody Health and Eden Health include unlimited clinician messaging in their base price, which is the strongest support model for managing nausea, constipation, fatigue, and sulfur burps. SHED includes scheduled check-ins as part of the concierge tier. SkinnyRx and GobyMeds offer message-based support during business hours. For severe side effects, all providers will direct users to seek in-person urgent care — telehealth has clear limits.

Which provider has the most transparent pricing?

GobyMeds and Embody Health display all-in pricing on their landing pages (medication + consultation + shipping) with no hidden initial fees. SkinnyRx and Eden Health publish base prices but add intake fees on the first month. SHED uses tiered concierge pricing that varies by plan. Our reviews list the all-in cost-per-month estimate for each provider so you can compare apples to apples.

Which provider offers multi-product attach (e.g., GLP-1 + NAD+)?

Sprout Health is the strongest multi-product option in 2026 — they bundle GLP-1 medications with NAD+ peptide therapy, BPC-157, and longevity-focused stacks. Embody Health adds lifestyle coaching and metabolic supplements to the GLP-1 prescription. SHED offers premium add-ons (B12, hydration, electrolyte panels) at the concierge tier. Standalone GLP-1 prescribers (Eden, SkinnyRx, GobyMeds) focus on the core medication only.

GLP-1 Evolution and Weight Loss: The Complete Resource

Q: What is GLP-1 Evolution?

GLP-1 Evolution is an independent educational resource for weight loss patients evaluating GLP-1 receptor agonists. We compare programs, track clinical evidence, and disclose affiliate relationships openly.

Q: How does GLP-1 cause weight loss?

GLP-1 receptor agonists slow gastric emptying, increase satiety signaling to the brain, and reduce reward-driven eating. The combined effect is reduced caloric intake without persistent hunger.

Affiliate Disclosure: This page contains affiliate links. GLP-1 Evolution may earn a commission when you click and make a purchase, at no extra cost to you. Our editorial rankings prioritize consumer value over commission rates. Full disclosure.

By GLP-1 Evolution Research Team | Last updated: May 18, 2026

TL;DR

GLP-1 Evolution is an independent educational site comparing GLP-1 weight loss programs.
The medication class works by slowing gastric emptying, increasing satiety, and dampening food reward.
Trial averages: semaglutide ~14.9% at 68 weeks (STEP-1); tirzepatide ~22.5% at 72 weeks (SURMOUNT-1); retatrutide investigational ~24.2% at 48 weeks (Phase 2).
Vetted US telehealth programs start at $149/month (compounded) vs $900-$1,400 (branded retail).
Most patients require long-term therapy to maintain weight loss.

Who We Are

GLP-1 Evolution is an independent educational publication covering the evolution of metabolic medicine — from the first GLP-1 receptor agonists through current dual agonists like tirzepatide to investigational triple agonists like retatrutide. We compare programs, summarize clinical evidence, and disclose affiliate relationships openly so readers can weigh our recommendations accordingly.

We are not a clinic. We don't prescribe. We help readers evaluate the telehealth and pharmacy options that exist, choose programs that match their needs, and ask their clinicians better questions.

How GLP-1 Causes Weight Loss

GLP-1 (glucagon-like peptide-1) is an incretin hormone released by L-cells in the small intestine after eating. It does three weight-relevant things:

Slows gastric emptying. Food stays in your stomach longer. You feel full longer.
Increases satiety signaling. GLP-1 receptors in the hypothalamus modulate hunger and fullness perception.
Reduces food reward. Some evidence suggests GLP-1 agonism dampens the dopamine response to highly palatable foods.

Tirzepatide adds GIP receptor agonism, which appears to amplify weight-loss effects beyond GLP-1 alone. Retatrutide adds glucagon receptor agonism, which may further enhance energy expenditure.

The Clinical Evidence Base

Semaglutide (STEP-1)

STEP-1 (Wilding et al., NEJM 2021, PMID 33567185) enrolled 1,961 adults with overweight or obesity (without diabetes). Semaglutide 2.4 mg once weekly plus lifestyle counseling produced mean weight reduction of 14.9% at 68 weeks vs 2.4% placebo. About 50% of treated patients lost ≥15% body weight; about 32% lost ≥20%.

Tirzepatide (SURMOUNT-1)

SURMOUNT-1 (Jastreboff et al., NEJM 2022, PMID 35658024) enrolled 2,539 non-diabetic adults with obesity. Tirzepatide 15 mg produced mean weight reduction of 22.5% at 72 weeks. About 57% lost ≥20%; about 36% lost ≥25%.

Retatrutide (Phase 2)

Phase 2 retatrutide data (Jastreboff et al., NEJM 2023, PMID 37296141) showed mean weight loss up to 24.2% at 48 weeks at the highest dose. Phase 3 TRIUMPH trials are ongoing. Not yet FDA-approved.

The Five Telehealth Programs We Track

Embody — $149/mo entry. Lowest entry pricing; unique GLP-1 gum format. View Embody →
Eden Health — $129 promo / $209 flat-rate. No dose escalation pricing. View Eden Health →
SHED — $199-$299/mo. Includes supplements + coaching + 10% money-back offer (marketing claim by SHED; individual results vary based on diet, exercise, medical history, and adherence). View SHED →
SkinnyRx — $179 first month. Cheap starter. View SkinnyRx →
GobyMeds — $199-$349/mo. Established player.

See our full provider comparison for detail.

What to Expect Month by Month

Weeks 1-4 (0.25 mg sema / 2.5 mg tirz): Appetite reduction. Some GI side effects. Possible 2-5 lb loss.
Weeks 5-8: Dose escalation begins. Larger satiety effect. Side effects may flare with each dose increase.
Weeks 9-16: Most patients on therapeutic dose. Weight loss typically 8-15% of starting weight.
Weeks 17-52: Continued gradual loss. Plateaus are common — adjust diet/activity or discuss dose change.
Year 2+: Maintenance phase. Continued therapy maintains the loss.

What Happens If You Stop

STEP-4 data showed that patients who stopped semaglutide at week 20 regained about two-thirds of their weight loss by week 68. Most clinicians now treat GLP-1s as long-term therapy similar to antihypertensives — the medication manages the underlying condition while you take it, but the condition recurs when you stop. Read our deeper analysis: what happens when you stop GLP-1.

Beyond the Medication: Muscle, Nutrition, Supplements

Rapid weight loss on GLP-1 therapy includes meaningful muscle loss alongside fat. Protective strategies — adequate protein (1.2-1.6 g/kg/day), resistance training 2-3x weekly, and key supplements — are covered in how to keep muscle on GLP-1 and best supplements to take with GLP-1.

Frequently Asked Questions

What is GLP-1 Evolution?

Independent educational publication comparing GLP-1 weight loss programs.

How does GLP-1 cause weight loss?

Slows gastric emptying, increases satiety, reduces food reward.

How much will I lose?

Trial averages: ~14.9% semaglutide, ~22.5% tirzepatide. Individual results vary.

How fast?

Appetite changes in 1-2 weeks; measurable weight loss in 4-8 weeks.

What if I stop?

Most patients regain ~two-thirds of loss within a year.

Most cost-effective program?

Embody at $149/mo entry; Eden at $209 flat-rate.